Seres Therapeutics, Inc.
MCRB
Revenue
0.00
0.000.00%
3 Months ChangeAssets
164.18M
▲24.37M▲17.43%
3 Months ChangeLiabilities
113.72M
▼-12.31M▼-9.77%
3 Months ChangeFree Cash Flow
26.88M
▲62.17M▲176.14%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-01
Form 8-K
ID: 0001193125-24-230144
2024-09-26
Form 8-K
ID: 0001193125-24-226929
2024-09-12
Form 8-K
ID: 0001193125-24-217627
2024-08-15
Form 8-K
ID: 0001140361-24-037388
2024-08-13
Form 10-Q
ID: 0000950170-24-095821
2024-08-13
Form 8-K
ID: 0001193125-24-199382
2024-08-06
Form 8-K
ID: 0001140361-24-035951
2024-08-06
Form 8-K
ID: 0001140361-24-035799
2024-05-08
Form 10-Q
ID: 0000950170-24-055159
2024-05-08
Form 8-K
ID: 0001193125-24-133766